Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area

World Journal of Gastroenterology

Volumn 9, Issue 9, 2003, Pages 2012-2016

  Fan, Chun Lei ^a   Wei, Lai ^a   Jiang, Dong ^a   Chen, Hong Song ^a   Gao, Yan ^a   Li, Ruo Bing ^a   Wang, Yu ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; LIVER ENZYME; VIRUS DNA; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; B SCAN; CHI SQUARE TEST; CHINA; CLEARANCE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; SEROCONVERSION; SERUM; SEX DIFFERENCE; SUPERINFECTION; VIROLOGY; VIRUS INHIBITION; VIRUS LOAD;

EID: 0141495057     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i9.2012     Document Type: Article

References (32)

1. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995; 22: 1101-1108
2. Crespo J, Lozano JL, De La Cruz F, Rodrigo L, Rodriguez M, San Miguel G, Artinano E, Pons-Romero F. Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994; 89: 1147-1151
3. Rodriguez M, Navascues A, Martinez A, Suarez S, Riestra S, Sala P, Gonzalez M, Rodrigo L. Prevalence of antibody to hepatitis C virus in chronic HBsAg carriers. Arch Virol 1992; 4 (Suppl): 327-328
4. Bradley DW, Maynard JE, McCaustland KA. Non-A, non-B hepatitis chimpanzees: Interference with acute hepatitis A virus and chronic hepatitis B virus infections. J Med Virol 1983; 11: 207-213
5. Liaw YF, Tsai SL, Chang JJ, Sheen IS, Chien RN, Lin DY, Chu CM. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994; 106: 1048-1053
6. Crespo J, Lozano JL, Carte B. Viral replication in patients with concomitant hepatitis B and C virus infections. Eur J Clin Microbiol Infect Dis 1997; 16: 445-451
7. Pontisso P, Gerotto M, Ruvoletto MG, Fettovich G, Chemello L, Tisminetzky S, Baralle F, Alberti A. Hepatitis C genotypes in patients with dual hepatitis B and C virus infection. J Med Virol 1996; 48: 157-160
8. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529-1533
9. Ohkawa K, Hayashi N, Yuki N, Masuzawa M, Kato M, Yamamoto K, Hosotsubo H, Deguchi M, Katayama K, Kasahara A. Long term follow-up of hepatitis B virus and hepatitis C virus replication levels in chronic hepatitis patients co-infected with both viruses. J Med Virol 1995; 46: 258-264
10. Sheen IS, Liaw YF, Lin DY, Chu CM. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 1992; 165: 831-834
11. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, Nhieu JT, Seigneurin JM, Buffet C, Dhumeaux D. Characteristic of patients with dual infection by hepatitis B and C viruses. J Hepat 1998; 28: 27-33
12. Shirazi LK, Petermann D, Muller C. Hepatitis B virus DNA in sera and liver tissue of HBeAg negative patients with chronic hepatitis C. J Hepatol 2000; 33: 785-790
13. Ishikawa T, Ichida T, Yamagiwa S, Sugahara S, Uehara K, Okoshi S, Asakura H. High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis. J Gastroenterol Hepatol 2001; 16: 1274-1278
14. Chiaramonte M, Stroffolini T, Vian A, Stazi MA, Floreani A, Lorenzoni U, Lobello S, Farinati F, Naccarato R. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999; 85: 2132-2137
15. Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Filippini P, Piccinino F. HCV genotype and "silent" HBV coinfection: Two main risk factors for a more severe liver disease. J Med Virol 2001; 64: 350-355
16. Lee DS, Huh K, Lee EH, Lee DH, Hong KS, Sung YC. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: Possibility of coinfection in these patients must be considered in HBV-high endemic area. J Gastroen Hepatol 1997; 12: 855-861
17. Colombari R, Dhillon AP, Piazzola E, Tomezzoli AA, Angelini GP, Capra F, Tomba A, Scheuer PJ. Chronic hepatitis in multiple virus infection: Histopathological evaluation. Histopathology 1993; 22: 319-325
18. Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer 1997; 80: 2060-2067
19. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J. Hepatitis B and C virus infections in patients with hepatocellular carcinoma. Hepatology 1992; 16: 637-641
20. Huang EJ, Wright TL, Lake JR, Combs C, Ferrell LD. Hepatitis B and hepatitis C coinfections and persistent hepatitis B infections: Clinical outcome and liver pathology after transplantation. Hepatology 1996; 23: 296-404
21. Wei L, Wang QX, Xu XY, Wan H, Gao Y, Tian XL, Yu M, Sun DG, Fan CL, Jin J, Fan WM, Yi LM, Zhu WF, Chen HS, Zhuang H, Wang Y. 12-25-Year follow-up of hepatitis C virus infection in a rural area of Hebei Province. Beijing Daxue Xuebao [Yixue Ban] 2002; 34: 574-578
22. Sagnelli E, Coppola N, Messina V, Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastico C, Filippini P. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course. Hepatology 2002; 36: 1285-1291
23. EASL International consensus conference on hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol 2003; 38: 533-540
24. Chinese Medical Association. The Programme for prevention and cure of viral hepatitis. Zhonghua Ganzangbing Zazhi 2000; 8: 324-329
25. Utili BR, Zampio R, Bellopede P, Marracino M, Ragone E, Adinolfi LE, Ruggiero G, Capasso M, Indolfi P, Casale F, Martini A, Tullio TD. Dual or single hepatitis B and C virus infection in childhood cancer survivior: Long term follow-up and effect of interferon treatment. Blood 1999; 94: 4046-4052
26. Liaw YF, Yeh CT, Tsai SL. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 2000; 95: 2978-2980
27. Chisari FV. Viruses, immunity, and cancer: Lessons from hepatitis B. Am J Pathol 2000; 156: 1117-1132
28. Uchida T, Kaneita Y, Gotoh K, Kanagawa H, Kouyama H, Kawanishi T, Mima S. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: Probable replication promotion of the latter as demonstrated by in vitro cotransfection. J Med Virol 1997; 52: 399-405
29. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J. Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotype and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001; 34: 404-410
30. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, Callea F, Verme G. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90: 1268-1273
31. Lohiya G, Lohiya S, Ngo VT, Crinella R. Epidemiology of hepatitis B e antigen and antibody in mentally retarded HBsAg carriers. Hepatology 1986; 6: 163-166
32. Sheen IS, Liaw YF, Lin DY, Chu CM. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier atate: A multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994; 170: 358-361